Rajan Sharma
Stock Analyst at Goldman Sachs
(0.04)
# 4,518
Out of 5,113 analysts
5
Total ratings
25%
Success rate
-56.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $24.44 | -70.34% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $95.60 | +1.46% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $50.80 | -7.48% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $35.05 | +125.39% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $24.44
Upside: -70.34%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $95.60
Upside: +1.46%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $50.80
Upside: -7.48%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $35.05
Upside: +125.39%